| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -158.99M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DFTX returned +328.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +225.8% |
| 1 year | +328.1% |
| 5 years | +0.6% |
| All-time high | $58.65 (Apr 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in DFTX would be worth today ›No. Definium Therapeutics, Inc. has not paid a dividend in the past 12 months.
Definium Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol DFTX.
Definium Therapeutics, Inc. is part of the Healthcare sector.
Definium Therapeutics, Inc. has a market cap of 5.86B USD, based on the latest quote.
Definium Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
